Basic Materials / Specialty ChemicalsBSE
$40.10
-1.90 (-4.52%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-19.6M · quality 33.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
38/100
D
Piotroski
4/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$243M
P/E
20.3x
↑EV/EBITDA
7.9x
↓ROE
19.7%
↑Gross Margin
8.6%
↓Debt/Equity
1.13
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+23.4%
FCF CAGR
—
FCF margin
-1.8%
FCF / Net income
-1.11x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.10B · net income $17.6M · FCF $-19.6M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.10B | $1.10B | $1.01B | $833.3M | $586.7M |
| Net Income | $17.6M | $17.6M | $18.5M | $22.7M | $56.1M |
| EBITDA | $44.6M | $44.6M | $38.6M | $38.5M | $84.0M |
| EPS | 2.91 | 2.91 | 3.06 | 3.74 | 9.25 |
| Gross Margin | 8.6% | 8.6% | 8.0% | 7.9% | 4.8% |
| Operating Margin | 2.4% | 2.4% | 3.0% | 3.0% | -0.4% |
| Net Margin | 1.6% | 1.6% | 1.8% | 2.7% | 9.6% |
| Balance Sheet | |||||
| Debt/Equity | 1.13 | 1.13 | 1.01 | 0.98 | 0.75 |
| Current Ratio | 1.09 | 1.09 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-19.6M | $-19.6M | $-19.9M | $-19.4M | $184.8M |
| Returns | |||||
| ROE | 19.7% | 19.7% | 25.7% | 42.3% | 182.1% |
| Valuation | |||||
| P/E | 20.25 | 20.25 | — | — | — |
| EV/EBITDA | 7.93 | 7.93 | — | — | — |
| P/B | 2.71 | 2.71 | — | — | — |
| Growth & Yield | |||||
| Revenue Growth | 9.6% | 9.6% | 20.8% | 42.0% | — |
| EPS Growth | -4.9% | -4.9% | -18.2% | -59.6% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
6.9%
EPS terminal req.
$3.56
Spread vs growth
-11.8%
5Y implied EPS CAGR
8.1%
EPS terminal req.
$4.31
Spread vs growth
-13.1%
10Y implied EPS CAGR
9.1%
EPS terminal req.
$6.93
Spread vs growth
-14.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-22.9%
Start / end P/E
17.0x → 13.8x
EPS bridge
3.06 → 2.91
Residual
+0.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.